Summing up the above scenarios it is likely that classical and alternative complement pathways as well as coagulation activation occur in SLE with APS and thrombosis, while complement activation on its own occurs in SLE with or without aPL and coagulation activation only in APS. The gene discussed is FASLG; the disease is systemic lupus erythematosus.